Steris (STE) Tops Q3 EPS by 15c
Tweet
Share
E-mailGet Alerts STE Hot Sheet
Price: $218.12 -2.88%
EPS Growth %: +8.5%
Financial Fact:
Income (loss) before income tax expense (benefit): 15.84M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +8.5%
Financial Fact:
Income (loss) before income tax expense (benefit): 15.84M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Steris (NYSE: STE) reported Q3 EPS of $2.12, $0.15 better than the analyst estimate of $1.97. Revenue for the quarter came in at $1.2 billion versus the consensus estimate of $1.2 billion.
GUIDANCE:
Steris sees FY2022 EPS of $7.85-$7.95, versus the consensus of $7.73.
For earnings history and earnings-related data on Steris (STE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- UiPath Inc. (PATH) Reports In-Line Q2 EPS; offers guidance
- GE Aerospace to acquire Consolidated Precision in $11.75b deal
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
